The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype: A population‐based study from the California cancer Registry
Abstract
BACKGROUND.: Tumor markers are becoming increasingly important in breast cancer research because of their impact on prognosis, treatment, and survival, and because of their relation to breast cancer subtypes. The triple‐negative phenotype is important because of its relation to the basal‐like subtype of breast cancer. METHODS.: Using the population‐based California Cancer Registry data, we identified women diagnosed with triple‐negative breast cancer between 1999 and 2003. We examined differences between triple‐negative breast cancers compared with other breast cancers in relation to age, race/ethnicity, socioeconomic status (SES), stage at diagnosis, tumor grade, and relative survival. RESULTS.: A total of 6370 women were identified as having triple‐negative breast cancer and were compared with the 44,704 women with other breast cancers. Women with triple‐negative breast cancers were significantly more likely to be under age 40 (odds ratio [OR], 1.53), and non‐Hispanic black (OR, 1.77) or Hispanic (OR, 1.23). Regardless of stage at diagnosis, women with triple‐negative breast cancers had poorer survival than those with other breast cancers, and non‐Hispanic black women with late‐stage triple‐negative cancer had the poorest survival, with a 5‐year relative survival of only 14%. CONCLUSIONS.: Triple‐negative breast cancers affect younger, non‐Hispanic black and Hispanic women in areas of low SES. The tumors were diagnosed at later stage and were more aggressive, and these women had poorer survival regardless of stage. In addition, non‐Hispanic black women with late‐stage triple‐negative breast cancer had the poorest survival of any comparable group. Cancer 2007. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
Livasy, C. A., Karaca, G., Nanda, R., Tretiakova, M. S., Olopade, O. I., Moore, D. T., & Perou, C. M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800528 · Cited by 1,063
Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
Foulkes, W. D. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg050 · Cited by 970
Socioeconomic status and breast cancer incidence in California for different race/ethnic groups
Yost, K., Perkins, C., Cohen, R., Morris, C., & Wright, W. (2001) · Cancer Causes & Control · doi:10.1023/a:1011240019516 · Cited by 965
Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
van der Groep, P., Bouter, A., van der Zanden, R., Menko, F. H., Buerger, H., Verheijen, R. H. M., van der Wall, E., & van Diest, P. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh114 · Cited by 798
The Relation between Health Insurance Coverage and Clinical Outcomes among Women with Breast Cancer
Ayanian, J. Z., Kohler, B. A., Abe, T., & Epstein, A. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290507 · Cited by 681
Race, Socioeconomic Status, and Breast Cancer Treatment and Survival
Bradley, C. J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.490 · Cited by 658
Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome
Chlebowski, R. T., Chen, Z., Anderson, G. L., Rohan, T., Aragaki, A., Lane, D., Dolan, N. C., Paskett, E. D., McTiernan, A., Hubbell, F. A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji064 · Cited by 656
Newman, L. A., Griffith, K. A., Jatoi, I., Simon, M. S., Crowe, J. P., & Colditz, G. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3472 · Cited by 362
Rodríguez-Pinilla, S. M., Sarrió, D., Honrado, E., Hardisson, D., Calero, F., Benitez, J., & Palacios, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2281 · Cited by 324
Shavers, V. L., Harlan, L. C., & Stevens, J. L. (2003) · Cancer · doi:10.1002/cncr.11051 · Cited by 311
Breast Cancer in African-American Women
Newman, L. A. (2005) · The Oncologist · doi:10.1634/theoncologist.10-1-1 · Cited by 185
Newman, L. A., Mason, J., Cote, D., Vin, Y., Carolin, K., Bouwman, D., & Colditz, G. A. (2002) · Cancer · doi:10.1002/cncr.10575 · Cited by 175
Wójcik, B. E., Spinks, M. K., & Optenberg, S. A. (1998) · Cancer · Cited by 154
Chu, K. C., Lamar, C. A., & Freeman, H. P. (2003) · Cancer · doi:10.1002/cncr.11411 · Cited by 144
Black/white differences in type of initial breast cancer treatment and implications for survival.
McWhorter, W. P., & Mayer, W. J. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.12.1515 · Cited by 144
Jatoi, I., Becher, H., & Leake, C. (2003) · Cancer · doi:10.1002/cncr.11604 · Cited by 133
African‐American/White differences in breast carcinoma
Jones, B. A., Kasl, S. V., Howe, C. L., Lachman, M. F., Dubrow, R., Curnen, M. G. M., Soler‐Vilá, H., Beeghly, A., Duan, F., & Owens, P. H. (2004) · Cancer · doi:10.1002/cncr.20500 · Cited by 113
Socioeconomic factors and breast cancer in black and white Americans
Gordon, N. H. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1022212018158 · Cited by 97
Tumor characteristics in African American and white women
Furberg, H. F., Millikan, R., Dressler, L., et al. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1017994726207 · Cited by 94
Disparities and Survival Among Breast Cancer Patients
Field, T. S. (2005) · JNCI Monographs · doi:10.1093/jncimonographs/lgi044 · Cited by 94
Cunningham, J. E., & Butler, W. M. (2004) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-0592-9 · Cited by 66
Breast Cancer and Race: A Rising Tide Does Not Lift All Boats Equally
Polite, B. N., & Olopade, O. I. (2005) · Perspectives in biology and medicine · doi:10.1353/pbm.2005.0027 · Cited by 32
Cited by
Foulkes, W. D., Smith, I. E., & Reis-Filho, J. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra1001389 · Cited by 4,157
Liedtke, C., Mazouni, C., Hess, K. R., André, F., Tordai, A., Mejia, J. A., Symmans, W. F., Gonzalez-Angulo, A. M., Hennessy, B., Green, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4147 · Cited by 2,892
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Nanda, R., Chow, L. Q. M., Dees, E. C., Berger, R., Gupta, S., Geva, R., Pusztai, L., Pathiraja, K., Aktan, G., Cheng, J. D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.8931 · Cited by 1,477
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
Schmid, P., Cortes, J., Dent, R., Pusztai, L., McArthur, H., Kümmel, S., Bergh, J., Denkert, C., Park, Y. H., Hui, R., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2112651 · Cited by 1,274
Metadata
- Authors
- Bauer, K. R., Brown, M., Cress, R. D., Parise, C. A., & Caggiano, V.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-04-18
- Volume
- 109
- Issue
- 9
- Pages
- 1721-1728
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1995224853
- Cited by
- 2,067
- References
- 32
- FWCI
- 26.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.